Did ZIOP stock beat earnings estimates in the most recent quarter?
ZIOPHARM ONCOLOGY INC (ZIOP) beat EPS estimates and missed revenue estimates in the most recent quarter.
NASDAQ:ZIOP
Past quarterly earnings results for ZIOPHARM ONCOLOGY INC (ZIOP), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in ): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2021 | -0.11 | -0.13 | 18.30% | -10.00% | 398K | - | - | |
| Q2 2021 | -0.11 | -0.12 | 10.13% | -22.22% | - | - | ||
| Q1 2021 | -0.10 | -0.11 | 6.63% | -11.11% | - | - | ||
| Q4 2020 | -0.11 | -0.10 | -9.21% | - | - | - | ||
| Q3 2020 | -0.10 | -0.09 | -8.93% | - | - | - | ||
| Q2 2020 | -0.09 | -0.09 | 3.49% | - | - | - | ||
| Q1 2020 | -0.09 | -0.08 | -5.89% | - | - | - |
Notes
ZIOPHARM ONCOLOGY INC (ZIOP) beat EPS estimates and missed revenue estimates in the most recent quarter.